← Eichor
Study identifier: NCT07261306 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis

Condition: Psoriasis  ·  Sponsor: Lahore General Hospital

PhaseEARLY_Phase 1
Planned participants75
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersYes

About this study

Psoriasis is a chronic inflammatory dermatoses which include well demarcated scaly erythematous plaques on whole body including scalp role of methotrexate vs tofacitinib is compared in this study

This description comes directly from the study's public registry record.

Talk to the study team

Maryam Fatima, Mbbs  ·  03361409014  ·  maryamfatima726@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Lahore general hospitalLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07261306